Insulin unaffordable for many in low-and middle-income countries

Lack of adequate infrastructure to manufacture or store insulin is a major hurdle many low- and middle-income countries face

US drug administration approves inhalable insulin, Afrezza

It is a new treatment option for patients with diabetes requiring mealtime insulin taken as inje